Cite
Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancy
MLA
Thomas G. Graeber, et al. Quantitative Single Cell Heterogeneity Profiling of Patient Derived Tumor Initiating Gliomaspheres Reveals Unique Signatures of Drug Response and Malignancy. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d52ea429f96ced2808ec094c305ff435&authtype=sso&custid=ns315887.
APA
Thomas G. Graeber, A. Nunez, Michael Masterman-Smith, E. E. Samuels, E. Panosyan, S. H. Lim, Nicholas A. Graham, Tiffany Phillips, Jack Mottahedeh, William H. Yong, Meeryo Choe, Jing Sun, Harley I. Kornblum, Ming-Fei Lang, & Koppany Visnyei. (2020). Quantitative single cell heterogeneity profiling of patient derived tumor initiating gliomaspheres reveals unique signatures of drug response and malignancy.
Chicago
Thomas G. Graeber, A. Nunez, Michael Masterman-Smith, E. E. Samuels, E. Panosyan, S. H. Lim, Nicholas A. Graham, et al. 2020. “Quantitative Single Cell Heterogeneity Profiling of Patient Derived Tumor Initiating Gliomaspheres Reveals Unique Signatures of Drug Response and Malignancy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d52ea429f96ced2808ec094c305ff435&authtype=sso&custid=ns315887.